Abstract
In the paper are presented the results of investigating protective effect of attenuated live vaccine against classical swine fever (CSF) under experimental conditions. The vaccine contains C-strain of CSF. In the Republic of Serbia it is used for systemic immunoprophylaxis. Potency testing was performed according to the guidelines of the European Pharmacopoeia, 5th Edition, 2005 (01/2005:0065) and the guidelines published by the World Organisation for Animal Health (OIE) (Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 5th Edition, 2008, Vol. 1, Chapter 2.8.3). The experiments were carried out on twelve weaner pigs seven weeks of age randomly assigned to two groups consisting of five, and one group consisting of two pigs. Before introducing the experimental protocol of vaccination and artificial infection, the presence of specific antibodies against CSF was controlled by ELISA test, i.e. by serum neutralisation test that proved no presence of antibodies against bovine virus diarrhea (BVD). The pigs in the fist group were vaccinated with attenuated live vaccine Lavir-K® (Veterinary Institute Zemun a.d. Belgrade) in a 1:40 dilution, and the pigs from second group were vaccinated in a 1:160 dilution. The group three served as a control group that was not vaccinated. Fourteen days post vaccination all animals were challenged with highly virulent CSF virus strain Beker, and fourteen days after artificial infection animals were daily observed and their body temperature was recorded. In the group of animals vaccinated with vaccine Lavir-K® in a 1:40 dilution there were no clinical characteristic symptoms of CSF, while in the group vaccinated in a 1:160 dilution two pigs became ill with obvious CSF symptoms. One pig died on day 7 p.v. In the control group, i.e. two non-vaccinated pigs, there was an acute form of CSF and they died seven days after the infection. Calculation of the Protective Dose 50 (PD50) of Lavir-K® was done using the equation by Spearman-Kaerber and it was calculated to be 184. Having in mind that one vaccine doses should have protective value of > 100, it may be concluded that tested vaccine fulfils the requirements for vaccine potency as laid down in the European Pharmacopoeia and the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.
Highlights
U radu su prezentovani rezultati ispitivanja zaštitnog delovanja atenuisane žive vakcine protiv klasične kuge svinja (KKS) u kontrolisanim eksperimentalnim uslovima
Fourteen days post vaccination all animals were challenged with highly virulent classical swine fever (CSF) virus strain Beker, and fourteen days after artificial infection animals were daily observed and their body temperature was recorded
In the group of animals vaccinated with vaccine Lavir-K® in a 1:40 dilution there were no clinical characteristic symptoms of CSF, while in the group vaccinated in a 1:160 dilution two pigs became ill with obvious CSF symptoms
Summary
U radu su prezentovani rezultati ispitivanja zaštitnog delovanja atenuisane žive vakcine protiv klasične kuge svinja (KKS) u kontrolisanim eksperimentalnim uslovima. Četrnaest dana nakon vakcinacije sve životinje su veštački inficirane visoko virulentnim sojem virusa KKS – soj Backer, a tokom dve nedelje nakon veštačke infekcije, životinje su svakodnevno klinički opservirane uključujući i termometriranje. U grupi životinja koja je vakcinisana vakcinom Lavir-K® pri razređenju 1:40 nisu ustanovljeni klinički znaci oboljenja karakterističnih za KKS, dok su u grupi. U kontrolnoj grupi životinja, odnosno kod dva nevakcinisana praseta došlo je do pojave karakteristične akutne forme KKS i uginuća u roku od sedam dana nakon infekcije. Ako se ima u vidu da jedna vakcinalna doza treba da sadrži protektivnu vrednost ≥100, može se zaključiti da efikasnost ispitivane vakcine ispunjava zahteve Evropske farmakopeje i zahteve OIE Priručnika o dijagnostičkim testovima i vakcinama za kopnene životinje.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
